As a global leader in the ADC segment, we offer end-to-end solutions through our state-of-the-art facilities in the UK and US. Our ADCelerate solution covers the entire development process, from pre-clinical stages to conjugated ADC manufacturing and fill/finish.

In our Grangemouth, UK Facility, we handle conjugation and GMP batch manufacturing for clinical and commercial ADCs. We seamlessly integrate this process with monoclonal antibodies sourced from our Yapan Bio facility in India. Yapan Bio specializes in process development, scale-up, and GMP-compliant manufacturing of biologics, including monoclonal antibodies. Finally, at our USFDA-inspected manufacturing facility in Lexington, KY, we perform aseptic filling of ADC drug products.

The capability to develop and manufacture your ADC and its components through a single CDMO provides a significant advantage in terms of both speed and quality.

Piramal's partnership with its associate company, Yapan Bio, expands our offerings to include development and manufacturing services for large molecules. Yapan Bio specializes in process development, scale-up, and GMP-compliant manufacturing of vaccines, Gene Therapy, MAbs, and other complex biologics.

Our services extend to our sterile injectable facility in Lexington, US, where we conduct clinical and commercial manufacturing of a wide range of injectable formulations, including vaccines and biologics. At Lexington, we produce parenteral drug products in both liquid and lyophilized dosage forms.

Piramal's integrated facilities and expert team ensure the success of your high-potency project. We specialize in formulating highly toxic compounds such as cytotoxics, hormones, controlled substances, and steroids into oral solids, liquids, or lyophilized products. Our Potent Solution services encompass HPAPI development and manufacturing, process development, clinical supply, and commercial manufacturing.

At our Ennore facility, we provide process development, early-phase clinical supplies, and custom manufacturing for RSMs, KSMs, and intermediates for NCEs. This process continues at our API site, specializing in HPAPI Development and GMP manufacturing for complex NCEs, with final formulation available in the dosage form of your choice.

Piramal's extensive expertise in sterile injectable formulation development and manufacturing can be back-integrated with our API facilities across the globe. We offer end-to-end solutions from early-stage drug development to intermediates, API, and formulation manufacturing.

Our sterile injectable facility in Lexington, US conducts clinical and commercial manufacturing of a wide range of injectable products. We provide personalized service with unmatched speed and flexibility, producing parenteral drug products in liquid and lyophilized forms. Innovative mobile isolator technology ensures the containment of potent and cytotoxic compounds while maintaining an aseptic manufacturing environment. 

As a leading player in the Peptide segment, we provide end-to-end solutions through our state-of-the-art facilities in India and the US. Our integrated services cover the entire spectrum from peptide early-stage discovery to API and formulation development, to its clinical & commercial manufacturing.

Our facility in Turbhe, India, offers strong expertise in developing and commercializing both solution phase and solid phase synthesis of peptide APIs. Furthermore, our services extend to our sterile injectable site in Lexington, US, where we conduct cGMP manufacturing of a wide range of injectable products, including peptides.

Piramal's extensive experience in OSD product development and manufacturing is supported by our globPiramal's extensive experience in API and high-potency API (HPAPI) development and manufacturing is supported by our global network of facilities. From API development to clinical supply, and commercial manufacturing of API, we offer tailored end-to-end solutions.

Beginning at our Discovery facility in Ahmedabad, we provide comprehensive early-stage drug discovery services. Following this, our facilities offer process development, early-phase clinical supplies, and manufacturing services for RSMs, KSMs, and intermediates. These services seamlessly integrate with cGMP development and API manufacturing in your preferred location.

Piramal's extensive OSD product development and manufacturing experience is backed by our globally integrated facility network. From drug discovery to API development, process development, clinical supply, and commercial manufacturing and packaging of solid oral dosage forms, we offer end-to-end solutions tailored to your needs.

Starting at our Discovery facility in Ahmedabad, we provide comprehensive early-stage drug discovery services. Subsequently, our facilities offer process development, early-phase clinical supplies, and manufacturing services for RSMs, KSMs, and intermediates. We seamlessly integrate these services with cGMP development and API manufacturing in your preferred location.

Our API sites further integrate services into OSD formulation development and manufacturing facilities in the geography of your preference.